Inducing Cancer Cell Killing Using DNA Nanostructure-Mediated Superclustering of Death Receptors

被引:0
|
作者
Aba, Go''ktug [1 ]
Abudukelimu, Subinuer [2 ]
de Winter, Margot [1 ]
Collu, Gabriella [1 ]
Bos, Erik [1 ]
Hamers, Sebastiaan M. W. R. [1 ]
Hawinkels, Lukas J. A. C. [2 ]
van Montfoort, Nadine [2 ]
Scheeren, Ferenc A. [3 ]
Sharp, Thomas H. [1 ,4 ]
机构
[1] Leiden Univ Med Ctr, Dept Cell & Chem Biol, NL-2333 ZG Leiden, Netherlands
[2] Leiden Univ Med Ctr, Dept Gastroenterol & Hepatol, NL-2333 ZG Leiden, Netherlands
[3] Leiden Univ Med Ctr, Dept Dermatol, NL-2333 ZG Leiden, Netherlands
[4] Univ Bristol, Sch Biochem, Bristol BS8 1TD, England
基金
欧盟地平线“2020”; 欧洲研究理事会;
关键词
TRAIL; DNA nanotechnology; Immunology; Death receptor; Cell killing; Nanomedicine; CASPASE ACTIVATION; AGONIST ANTIBODY; AMG; 655; APOPTOSIS; CONATUMUMAB; CYTOKINE; FAMILY; LIGAND;
D O I
10.1021/acs.nanolett.5c01122
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Clustering of type-II tumor necrosis factor receptors (TNFRs) is required to induce intracellular signaling. Current methods for receptor clustering lack precise control over ligand valency and spatial organization, potentially limiting optimal TNFR activation, biological insight, and therapeutic efficacy. DNA nanostructures provide nanometer-precise control over molecular arrangement, allowing control of both ligand spacing and valency. Here, we produce a DNA nanostructure decorated with controlled numbers of engineered single-chain TNF-related apoptosis-inducing ligand (sc-TRAIL) trimers, which bind death receptor 5 (DR5) with native affinity and geometry and enable investigation of the geometric parameters influencing apoptotic pathway activation. We show that cell killing is affected by receptor valency and separation and enhanced by superclustering sc-TRAIL trimers, which can induce cell killing in human primary pancreatic and colorectal cancer organoids. Together, our data show that control of receptor superclustering enhances our understanding of receptor activation mechanisms and informs the development of more effective cancer therapies.
引用
收藏
页码:6310 / 6317
页数:8
相关论文
共 50 条
  • [1] Targeting death-inducing receptors in cancer therapy
    Takeda, K.
    Stagg, J.
    Yagita, H.
    Okumura, K.
    Smyth, M. J.
    ONCOGENE, 2007, 26 (25) : 3745 - 3757
  • [2] Targeting death-inducing receptors in cancer therapy
    K Takeda
    J Stagg
    H Yagita
    K Okumura
    M J Smyth
    Oncogene, 2007, 26 : 3745 - 3757
  • [3] Calmodulin Binding to Death Receptor 5-mediated Death-Inducing Signaling Complex in Breast Cancer Cells
    Fancy, Romone M.
    Kim, Harrison
    Zhou, Tong
    Zinn, Kurt R.
    Buchsbaum, Donald J.
    Song, Yuhua
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2017, 118 (08) : 2285 - 2294
  • [4] Rapid and efficient cancer cell killing mediated by high-affinity death receptor homotrimerizing TRAIL variants
    Reis, C. R.
    van der Sloot, A. M.
    Natoni, A.
    Szegezdi, E.
    Setroikromo, R.
    Meijer, M.
    Sjollema, K.
    Stricher, F.
    Cool, R. H.
    Samali, A.
    Serrano, L.
    Quax, W. J.
    CELL DEATH & DISEASE, 2010, 1 : e83 - e83
  • [5] Rapid and efficient cancer cell killing mediated by high-affinity death receptor homotrimerizing TRAIL variants
    C R Reis
    A M van der Sloot
    A Natoni
    E Szegezdi
    R Setroikromo
    M Meijer
    K Sjollema
    F Stricher
    R H Cool
    A Samali
    L Serrano
    W J Quax
    Cell Death & Disease, 2010, 1 : e83 - e83
  • [6] Two death-inducing human TRAIL receptors to target in cancer: Similar or distinct regulation and function?
    van Roosmalen, Ingrid A. M.
    Quax, Wim J.
    Kruyt, Frank A. E.
    BIOCHEMICAL PHARMACOLOGY, 2014, 91 (04) : 447 - 456
  • [7] killerFLIP: a novel lytic peptide specifically inducing cancer cell death
    Pennarun, B.
    Gaidos, G.
    Bucur, O.
    Tinari, A.
    Rupasinghe, C.
    Jin, T.
    Dewar, R.
    Song, K.
    Santos, M. T.
    Malorni, W.
    Mierke, D.
    Khosravi-Far, R.
    CELL DEATH & DISEASE, 2013, 4 : e894 - e894
  • [8] Nanoscale Organization of TRAIL Trimers using DNA Origami to Promote Clustering of Death Receptor and Cancer Cell Apoptosis
    Ma, Nana
    Cheng, Keman
    Feng, Qingqing
    Liu, Guangna
    Liang, Jie
    Ma, Xiaotu
    Chen, Zhiqiang
    Lu, Yichao
    Wang, Xinwei
    He, Wei
    Xu, Hu
    Wu, Shan
    Zou, Jiajia
    Shi, Quanwei
    Nie, Guangjun
    Zhao, Xiao
    SMALL, 2023, 19 (23)
  • [9] Inducing cancer cell death by targeting transcription factors
    Kim, R
    Tanabe, K
    Emi, M
    Uchida, Y
    Inoue, H
    Toge, T
    ANTI-CANCER DRUGS, 2003, 14 (01) : 3 - 11
  • [10] Citrus limon-derived nanovesicles inhibit cancer cell proliferation and suppress CML xenograft growth by inducing TRAIL-mediated cell death
    Raimondo, Stefania
    Naselli, Flores
    Fontana, Simona
    Monteleone, Francesca
    Lo Dico, Alessia
    Saieva, Laura
    Zito, Giovanni
    Flugy, Anna
    Manno, Mauro
    Di Bella, Maria Antonietta
    De Leo, Giacomo
    Alessandro, Riccardo
    ONCOTARGET, 2015, 6 (23) : 19514 - 19527